General Announcement::GPL has entered into an agreement to become a partner in ABCD Technologies LLP

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
30-Apr-2021 22:04:21
Status
New
Announcement Sub Title
GPL has entered into an agreement to become a partner in ABCD Technologies LLP
Announcement Reference
SG210430OTHRG5Z2
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
30/04/2021 00:00:00
Description (Please provide a detailed description of the event in the box below)
Sub: Disclosure under Regulation 30 of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015

This is to inform you that Glenmark Pharmaceuticals Limited has entered into an agreement to become a partner in ABCD Technologies LLP (to be renamed as Indo Health Services LLP).

The details required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are enclosed as Annexure A.

Request you to kindly take the same on record.

Attachments

SGX_REG30_30042021.pdf
Total size =354K